| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e77f078aa3c0f82295fd660f1d639366 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
| filingDate |
2020-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_288f28259fe5d2835087da3ad7f237be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27dd00ae519c5c1350b364070c5ce15e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_535c206297a688d34eb09f35d1ae6dad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5bd94d2271e6d7b5c664667fd59ec36 |
| publicationDate |
2020-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020175897-A1 |
| titleOfInvention |
Controlled release formulation containing mirabegron or pharmaceutically acceptable salt thereof |
| abstract |
The present invention relates to a controlled release formulation comprising: Mirabegron or a pharmaceutically acceptable salt thereof; an isomalt; and a sustained release agent. Disclosed is a formulation in which Mirabegron, a medication, does not decompose, and thus the therapeutic effect thereof can be maintained constant during long-term storage. Moreover, Mirabegron can be released stably and sustainably in vivo, and thus a sufficient medicinal effect can be exhibited even when the formulation is administered once a day. |
| priorityDate |
2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |